Supplementary Figure S11 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
Abstract
Supplementary Figure S11: In vitro phagocytosis, in vivo anti-tumor efficacy, and body weight change data of TJH2201.
Fields of Study & Subjects
Phagocytosis and Immune Regulation
Erythrocyte Function and Pathophysiology
Chemokine receptors and signaling
Publication details
- Publisher
- American Association for Cancer Research (AACR)
- Publication date
- 2 January 2026